A detailed history of Peapack Gladstone Financial Corp transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 10,295 shares of BHC stock, worth $85,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,295
Previous 10,602 2.9%
Holding current value
$85,036
Previous $112,000 35.71%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$6.1 - $10.41 $1,872 - $3,195
-307 Reduced 2.9%
10,295 $72,000
Q1 2024

May 10, 2024

SELL
$7.77 - $10.61 $27,684 - $37,803
-3,563 Reduced 25.15%
10,602 $112,000
Q4 2023

Feb 13, 2024

SELL
$6.53 - $8.23 $26,746 - $33,710
-4,096 Reduced 22.43%
14,165 $114,000
Q3 2023

Nov 14, 2023

BUY
$7.69 - $9.71 $415 - $524
54 Added 0.3%
18,261 $150,000
Q2 2023

Aug 14, 2023

SELL
$5.72 - $8.8 $35,504 - $54,621
-6,207 Reduced 25.42%
18,207 $146,000
Q1 2023

May 15, 2023

SELL
$6.28 - $9.85 $46,227 - $72,505
-7,361 Reduced 23.17%
24,414 $198,000
Q4 2022

Feb 14, 2023

SELL
$6.09 - $7.93 $13,002 - $16,930
-2,135 Reduced 6.3%
31,775 $200,000
Q3 2022

Nov 10, 2022

SELL
$4.58 - $9.21 $35,046 - $70,474
-7,652 Reduced 18.41%
33,910 $234,000
Q2 2022

Aug 12, 2022

SELL
$7.06 - $23.63 $5,174 - $17,320
-733 Reduced 1.73%
41,562 $347,000
Q1 2022

May 16, 2022

BUY
$21.6 - $27.79 $10,908 - $14,033
505 Added 1.21%
42,295 $966,000
Q4 2021

Feb 15, 2022

SELL
$23.0 - $29.01 $28,980 - $36,552
-1,260 Reduced 2.93%
41,790 $1.15 Million
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $10,917 - $13,106
-436 Reduced 1.0%
43,050 $1.2 Million
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $24,412 - $29,103
890 Added 2.09%
43,486 $1.28 Million
Q1 2021

May 14, 2021

BUY
$21.37 - $34.38 $910,276 - $1.46 Million
42,596 New
42,596 $1.35 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.99B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.